The recent outbreak of Bundibugyo virus in Congo is raising significant concerns. This virus, a less common relative of Ebola, has already claimed over 200 lives. Unfortunately, there are currently no specific treatments or vaccines available, making it tough for healthcare workers on the ground.
Dr. Celine Gounder, an expert in infectious diseases, points out that clinical trials for potential treatments are lacking. She notes that responders are relying on fundamental healthcare practices, which was also the case during the Ebola outbreak from 2014 to 2016.
The World Health Organization (WHO) has been researching possible vaccines and therapies to combat the virus. However, any promising solutions are still in the early stages and will take months to develop.
Bundibugyo virus is known to spread through contact with bodily fluids from infected individuals, making healthcare workers and family members particularly vulnerable. Dr. Tom Ksiazek, a virologist, explains that the virus has caused only a few outbreaks, allowing experts to have a clearer idea about its danger level. While it may be slightly less lethal than other Ebola strains, it still poses a significant risk.
Early identification of cases and immediate public health responses are crucial. For instance, in past Bundibugyo outbreaks, prompt isolation of patients led to better outcomes. Supportive care, such as hydration, greatly helps to reduce mortality.
Currently, the WHO is examining a few potential vaccine candidates:
- One is a modified version of Merck’s Ervebo vaccine, aimed at a more specific Bundibugyo strain.
- Another is being developed by India’s Serum Institute and is built on a platform similar to the Oxford-AstraZeneca COVID-19 vaccine.
Additionally, three therapies have been prioritized for clinical trials, including antibody treatments from companies like Mapp Biopharmaceutical and Regeneron, as well as Gilead Sciences’ antiviral drug, remdesivir.
Public health workers are actively tracing contacts of infected individuals and educating communities. In earlier Ebola outbreaks, safe burial practices were vital to control the virus, as funerals often exacerbated the spread. Epidemiologist Lina Moses emphasizes that even without a vaccine, effective public health measures, like education and quick testing, are still powerful tools.
Every Ebola outbreak in the Democratic Republic of the Congo has been contained so far, and experts are hopeful that this one can be managed similarly.
For more information on the medical response to outbreaks like Bundibugyo, you can refer to the WHO’s resources here.
